4//SEC Filing
SHALLCROSS STEVEN A 4
Accession 0001104659-26-001388
CIK 0000894158other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:55 PM ET
Size
6.1 KB
Accession
0001104659-26-001388
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Award
Stock Options (right to buy)
2026-01-05+475,000→ 475,000 totalExercise: $0.24From: 2026-02-01Exp: 2033-01-04→ Common Stock (475,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 36 months.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001263501
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:55 PM ET
- Size
- 6.1 KB